Impact Biomedical (IBO) Non Operating Income (2023 - 2025)
Impact Biomedical (IBO) posted Non Operating Income of $3000.0 for Q3 2025, little changed on a QoQ basis from $3000.0 in Q2 2025, and little changed year-over-year from $3000.0 in Q3 2024.
Impact Biomedical (IBO) Non Operating Income (2023 - 2025) Analysis & Trends
Impact Biomedical's Non Operating Income history runs 3 years deep, the most recent figure standing at $3000.0 for Q3 2025.
- Quarterly Non Operating Income changed 0.0% year-over-year to $3000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $12000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $13000.0, changed 0.0% from the prior year.
- Non Operating Income was $3000.0 for Q3 2025 at Impact Biomedical, roughly flat from $3000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $3000.0 in Q3 2023 and bottomed at $3000.0 in Q3 2023.
- A 3-year average of $3000.0 and a median of $3000.0 in 2023 frame the typical range for Non Operating Income.
- Peak annual rise in Non Operating Income reached 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
- Impact Biomedical's Non Operating Income stood at $3000.0 in 2023, then changed by 0.0% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025.
- Business Quant data shows IBO's Non Operating Income at $3000.0 in Q3 2025, $3000.0 in Q2 2025, and $3000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 3,000.00 |